Theraclone Sciences is a leading brand in the field of antibody research and development. With their extensive screening technology, they are able to identify the rare antibodies produced by the human immune system that have evolved to effectively cure infections and combat diseases. For over a decade, Theraclone Sciences has perfected their platform technology to discover these human monoclonal antibodies for the development of safe and effective therapeutic products.

Theraclone Sciences has licensed their HIV broadly neutralizing fully-human antibodies to Gilead, who is currently developing them as part of an HIV-cure regimen. Additionally, their platform technology has been licensed to OncoResponse for use in the field of oncology. For more information about Theraclone Sciences and their groundbreaking research, you can visit their website.

Their headquarters are located at 1124 Columbia Street, Suite 300, Seattle, WA 98104. If you have any inquiries, you can contact them at 206. 805.

1600 or send a fax to 206. 805. 1699.

© 2015 Theraclone Sciences